[Research progress of anti-fibrotic drugs that inhibit epithelial-mesenchymal transition in pulmonary fibrosis].

Zhang, L B; Zhao, N; Nong, Q Y

Zhang, L B; Zhao, N; Nong, Q Y.

Afiliação

Zhang LB; Department of Occupational Medical Laboratory of Guangdong Province Hospital For Occupational Disease Prevention And Treatment, Guangzhou 510300, China Acute Infectious Disease Control Department of Zengcheng Dstrict Center For Disease Control And Prevention, Guangzhou, 511399, China.
Zhao N; Department of Occupational Medical Laboratory of Guangdong Province Hospital For Occupational Disease Prevention And Treatment, Guangzhou 510300, China.
Nong QY; Department of Occupational Medical Laboratory of Guangdong Province Hospital For Occupational Disease Prevention And Treatment, Guangzhou 510300, China.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi ; 41(1): 72-77, 2023 Jan 20.

Article em Zh | MEDLINE | ID: mdl-36725301

Assuntos

Antifibróticos; Transição Epitelial-Mesenquimal; Fibrose Pulmonar; Humanos; Transição Epitelial-Mesenquimal/efeitos dos fármacos; Fibrose/tratamento farmacológico; Fibrose Pulmonar/tratamento farmacológico; Fibrose Pulmonar/metabolismo; Fibrose Pulmonar/patologia; Transdução de Sinais; Fator de Crescimento Transformador beta1/metabolismo; Antifibróticos/farmacologia; Antifibróticos/uso terapêutico

Palavras-chave

Epithelial-mesenchymal transition; Pulmonary fibrosis; Transforming growth factor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Transição Epitelial-Mesenquimal / Antifibróticos Limite: Humans Idioma: Zh Revista: Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi Assunto da revista: MEDICINA OCUPACIONAL Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google